Poonia Nisha, Kumar Aman, Kumar Vijay, Yadav Monika, Lal Kashmiri
Department of Chemistry, Guru Jambheshwar University of Science and Technology, Hisar, Haryana 125001, India.
Curr Top Med Chem. 2021;21(23):2109-2133. doi: 10.2174/1568026621666210913122828.
The need to overcome ever-increasing cases of antifungal resistance and circumvent side effects and drug interactions related to currently available drugs has impelled the demand to expedite the drug discovery and the development of novel antifungals. 1,4-disubstituted 1,2,3-triazole has gained tremendous interest in the last two decades mainly because of its ease of synthesis via copper( I)-catalyzed azide-alkyne cycloaddition (CuAAC) and its broad spectrum of chemotherapeutic potential. 1,2,3-Triazole is an excellent pharmacophore that has been used as a bioisostere for obtaining libraries of new medicinally important scaffolds. The present review focuses on the recent advances (2016-2021) in 1,2,3-triazole derivatives obtained by CuAAC as potential antifungal agents that may facilitate the triazole-based antifungal development process.
克服日益增多的抗真菌耐药性病例以及规避与现有药物相关的副作用和药物相互作用的需求,推动了加快新型抗真菌药物研发的需求。在过去二十年中,1,4 - 二取代的1,2,3 - 三唑引起了极大关注,主要是因为它可以通过铜(I)催化的叠氮化物 - 炔烃环加成反应(CuAAC)轻松合成,并且具有广泛的化疗潜力。1,2,3 - 三唑是一种出色的药效基团,已被用作生物电子等排体,以获得具有重要药用价值的新支架文库。本综述重点关注通过CuAAC获得的1,2,3 - 三唑衍生物作为潜在抗真菌剂的最新进展(2016 - 2021年),这可能会促进基于三唑的抗真菌药物研发进程。